Cours Respirerx Pharmaceuticals Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2021 | - | CA 2022 | - | Capitalisation | 289 k 257 k |
---|---|---|---|---|---|
Résultat net 2021 | -3 M -2,67 M | Résultat net 2022 | -2 M -1,78 M | VE / CA 2021 | - |
Dette nette 2021 | 2,08 M 1,85 M | Dette nette 2022 | 2,71 M 2,41 M | VE / CA 2022 | - |
PER 2021 |
-0,29
x | PER 2022 |
-0,06
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 93,37% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/10/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Director/Board Member | - | 22/03/23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,89% | 121 Md | |
+18,61% | 112 Md | |
+4,43% | 22,57 Md | |
-18,25% | 20,82 Md | |
-13,60% | 16,3 Md | |
-16,61% | 16,19 Md | |
-43,53% | 16,17 Md | |
+2,17% | 13,17 Md | |
+26,07% | 11,11 Md |
- Bourse
- Actions
- Action RSPI
- Action